Endometriosis Trial, Recruiting NCT07469007 Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Condition: Endometriosis
Back to Endometriosis

Endometriosis Trial, Recruiting

NCT07469007
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 39 years old
  • You have been found (through an MRI scan or keyhole surgery) to have signs of severe, deep endometriosis in the back part of the pelvis
  • You are covered by a social security or health insurance plan
  • You have been fully informed about the trial and have agreed to take part in writing

Who may not be able to join:

  • You have a cyst on your ovary related to endometriosis that is larger than 5 mm
  • You have previously had surgery specifically to treat severe deep endometriosis
  • Your ovaries have significantly reduced function, based on specific hormone and ultrasound results (confirm with trial site)
  • You are currently using, or have used in the past 3 months, a specific type of hormone treatment called a GnRH agonist (confirm with trial site)
  • Your Body Mass Index (BMI) — a measure of body weight relative to height — is above 35
  • You have gone through menopause
  • You are currently taking part in another clinical trial that restricts you from joining additional studies
  • You are under any form of legal guardianship or protection, or your freedom has been restricted by a legal or official decision
  • You are currently pregnant, breastfeeding, or have recently given birth

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0033683346567

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Registry
ClinicalTrials.gov
Start date
11 February 2025
Est. completion
1 January 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Percentage change in AMH (anti-mullerian hormone) levels between day 0 and month 12.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov